Benchmark Almanac

Robot Capabilities Index (Robocurve)

Not in model cards

An index fitted like Epoch ECI over five RoboDojo-RC Tier 1 tasks run by frontier LLMs on real YAM arms. Anchored at GPT-5.6 Sol minus 3 and GPT-6 Astra plus 3.

Pilot published 2026-10-15 with 9 frontier models and 1,055 trials. Gemini models score higher than their ECI predicts. RCI tracks Blueprint-Bench 2 best (r = 0.85).

Made by Robocurve Released Oct 2026 Real robots Tasks kept private
Level
Everyday Most adults, without training
Scored
Graded by people Human experts grade or compare the outputs.
Answers
Agent task Many steps in a terminal, browser, desktop, app, game or robot.

No scores here yet

No lab, leaderboard or Epoch AI run has reported a score for Robot Capabilities Index (Robocurve) yet.

No lab model card reports it yet

We read the headline results of 479 launch posts from 51 labs, and none of them list this benchmark.

More in Robotics

All 86 in Robotics
  • ERQA In use 400 multiple-choice visual questions from robot and egocentric footage on spatial, trajectory, action and state reasoning. Accuracy. Gemini Robotics ER 2 78.5%
  • RoboLab In use Zero-shot DROID Franka policies in Isaac Lab on 120 tabletop tasks at three instruction levels, 10 episodes each. Success rate. GR00T N1.7 8.58%
  • Human proximity (Google DeepMind robotics) In use Models judge from robot camera views whether a human is within 1 meter, a spatial awareness check for safe robot behavior. Scored by accuracy. Gemini Robotics ER 2 93%
  • Moment finding (Google DeepMind) In use Models find the moment in a robot video when an event happens. Scored by accuracy and mean absolute time distance in seconds. Gemini Robotics ER 2 91.3%
  • Progress classification (Google DeepMind) In use Models assign each frame of a robot video to one of five task-progress bands from 0 to 100 percent. Scored by accuracy. Gemini Robotics ER 2 57.4%
  • LIBERO Fading Simulated Franka tabletop tasks in four 10-task suites. Policies fine-tuned on 50 demos per task. Success rate over ~50 trials. MolmoAct 2 97.2%